Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Telaprevir in Triple Therapy on Intrahepatic Immunological Mechanisms.

NCT01641094 is registered in ClinicalTrials.gov with Foundation for Liver Research as lead sponsor.

NCT NCT01641094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01641094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Telaprevir in Triple Therapy on Intrahepatic Immunological Mechanisms.
Lead sponsor
Foundation for Liver Research
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
December 31, 2014
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c